Willow Shah-neville

Newsletter Signup - Under Article / In Page "*" indicates required fields Vision loss remains one of the leading causes of disability worldwide, with millions affected by inherited retinal diseases, age-related macular degeneration, and diabetic eye disea... See more

Breast cancer treatments heat up: Six therapies poised to transform patient outcomes By Willow Shah-Neville 13 minutesmins February 9, 2026 13 minutesmins Photo credits: Angiola Harry Newsletter Signup - Under Article / In Page"*" indicates required field... See more

The biggest biotech funding rounds in January 2026 By Willow Shah-Neville 4 minutesmins February 4, 2026 4 minutesmins Photo credits: Dmytro Demidko Newsletter Signup - Under Article / In Page"*" indicates required fieldsFacebookThis field is for validati... See more

Newsletter Signup - Under Article / In Page "*" indicates required fields As 2026 gets underway, Johnson & Johnson (J&J) is navigating an inflection point that involves balancing a maturing internal pipeline with evolving external pressures on pri... See more

Newsletter Signup - Under Article / In Page "*" indicates required fields Over the past decade, RNA interference (RNAi) technology has matured into a clinically validated therapeutic approach, with multiple small interfering RNA (siRNA) drugs delivering d... See more